Literature DB >> 30848447

Eosinophilic esophagitis after total gastrectomy treated with proton pump inhibitors: a case report.

Takashi Owaki1,2, Hiroki Sato3,4, Ryoko Horigome1, Satoru Hashimoto2, Terasu Honma1, Shuji Terai2.   

Abstract

Eosinophilic esophagitis (EoE) is a chronic, immune-mediated disorder in the esophagus characterized by symptoms related to esophageal dysfunction and eosinophil-predominant inflammation. EoE and Gastro Esophageal Reflux Disease (GERD) are known not to be mutually exclusive and share a complex relationship. Proton pump inhibitors (PPIs), which are generally used in the treatment of GERD, could be used to treat esophageal eosinophilia in suspected EoE. We report a rare case of EoE after total gastrectomy that responded to PPIs. Our case indicates that the onset of EoE does not necessarily require an acid reflux-induced antigen-mediated drive, and the action of PPIs in patients with active EoE is unrelated to gastric acid suppression.

Entities:  

Keywords:  Eosinophilic esophagitis; Gastrectomy; Gastro esophageal reflux disease; PPI-responsive esophageal eosinophilia; Proton pump inhibitor

Mesh:

Substances:

Year:  2019        PMID: 30848447     DOI: 10.1007/s12328-019-00960-4

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  23 in total

1.  Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.

Authors:  Alex Straumann; Sebastien Conus; Lukas Degen; Cornelia Frei; Christian Bussmann; Christoph Beglinger; Alain Schoepfer; Hans-Uwe Simon
Journal:  Clin Gastroenterol Hepatol       Date:  2011-01-28       Impact factor: 11.382

2.  Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system.

Authors:  Ikuo Hirano; Nelson Moy; Michael G Heckman; Colleen S Thomas; Nirmala Gonsalves; Sami R Achem
Journal:  Gut       Date:  2012-05-22       Impact factor: 23.059

3.  Eosinophilic esophagitis: interactions with gastroesophageal reflux disease.

Authors:  Edaire Cheng; Rhonda F Souza; Stuart Jon Spechler
Journal:  Gastroenterol Clin North Am       Date:  2014-03-24       Impact factor: 3.806

4.  Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia.

Authors:  Jason E Dranove; Debra S Horn; Miriam A Davis; Kevin M Kernek; Sandeep K Gupta
Journal:  J Pediatr       Date:  2008-09-10       Impact factor: 4.406

Review 5.  Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications.

Authors:  Ramalinga R Kedika; Rhonda F Souza; Stuart Jon Spechler
Journal:  Dig Dis Sci       Date:  2009-11       Impact factor: 3.199

Review 6.  Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.

Authors:  P B Miner
Journal:  Aliment Pharmacol Ther       Date:  2006-03       Impact factor: 8.171

Review 7.  Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.

Authors:  Glenn T Furuta; Chris A Liacouras; Margaret H Collins; Sandeep K Gupta; Chris Justinich; Phil E Putnam; Peter Bonis; Eric Hassall; Alex Straumann; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2007-08-08       Impact factor: 22.682

8.  Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study.

Authors:  Evan S Dellon; Olga Speck; Kimberly Woodward; Jessica H Gebhart; Ryan D Madanick; Sidney Levinson; Karen J Fritchie; John T Woosley; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2013-10-22       Impact factor: 10.864

9.  Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD.

Authors:  Edaire Cheng; Xi Zhang; Xiaofang Huo; Chunhua Yu; Qiuyang Zhang; David H Wang; Stuart Jon Spechler; Rhonda F Souza
Journal:  Gut       Date:  2012-05-12       Impact factor: 23.059

10.  Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells.

Authors:  Xi Zhang; Edaire Cheng; Xiaofang Huo; Chunhua Yu; Qiuyang Zhang; Thai H Pham; David H Wang; Stuart J Spechler; Rhonda F Souza
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more
  1 in total

Review 1.  Symptom-based diagnostic approach for eosinophilic esophagitis.

Authors:  Yasuhiro Fujiwara
Journal:  J Gastroenterol       Date:  2020-07-27       Impact factor: 7.527

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.